Been here for about 2 years as well. Traded it a couple of times back in the mad days of dec '17 and jan '18 but in for the longer haul now. I can understand why you might not like the way Dhillon manages EMH. The corporate structure here is almost incestuous. On the surface of it, it looks like Emerald Sciences is creaming it for themselves and for the benefit of Dhillon and his family. The 'consultancy fees', the credit facility at 12%, the related party transactions. All of that should set alarm bells ringing for any investor. On the other hand though EMH has not diluted it's shares in the same way as others. They haven't raised and burnt through crazy money building a notional 'global' business. They tend to make deals. The sweetest deal of all in the whole sector being the Pure Sunfarms JV with VFF. Add the manufacturing deal with Factors. 1200 acres of hemp with the ability to process it. All done with a minimum of CAPEX. XLY just announced a potentially $6 million deal for 300 acres of hemp. Now there's a company who knows how to burn through shareholders cash. If everything that EMH has in the pipeline comes to fruition, as it's beginning to do,then buying now at around $2 could be a very profitable investment. Not questioning you're judgement at all MyKnight you may well be right but bailing out of EMF at this point seems mis-timed. I was buying more last week. EMH is a monster in the making. There are risks here for sure but as revenue and profits grow only Dhillon can mess it up now for shareholders and who knows what's going on in his mind. Them's the risks we take. No risk no reward.